/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / D2B3 Neuro

D2B3 Neuro

New Haven, United States

D2B3 is a pre-clinical biotechnology company dedicated to advancing drug delivery solutions to the brain and central nervous system.

Healthcare & Biotech

D2B3 Neuro, based in New Haven, United States, has 2 investors on file, among them Connecticut Innovations and Creative Destruction Lab. Its site was last checked 13 Nov 2026: site answers.

d2b3.bio

Investors

2 investors on file
InvestorEvidenceType
Connecticut InnovationsPortfolio pageVenture capital
Creative Destruction LabPortfolio pageAccelerator

More from Connecticut Innovations

180 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (35%), AI & Machine Learning (11%), Fintech (11%).

AbbratechAbbraTech discovers and engineers antibodies against disease targets u…AeromicsAeromics is a clinical-stage pharmaceutical company developing a thera…Allyx TherapeuticsAllyx Therapeutics is developing oral small molecule therapies to trea…ArvinasArvinas develops targeted protein degradation therapeutics for serious…Biohaven PharmaceuticalsBiohaven is a biopharmaceutical company focused on the discovery, deve…

See Connecticut Innovations' full profile · Who invests alongside it

More from Creative Destruction Lab

1,552 companies on its checked portfolio

Its portfolio leans to AI & Machine Learning (26%), Healthcare & Biotech (22%), Industrial & Manufacturing (14%).

ARCTORISArctoris provides automated wet lab biology R&D and data generation se…Accipiter BiosciencesAccipiter Biosciences designs and develops protein therapies to addres…Adept MaterialsAdept Materials develops a technology for managing vapor, humidity, an…AegiqAegiq is building fault-tolerant quantum computers by combining determ…AitiologicAitiologic is a precision medicine startup providing multi-modal liqui…

See Creative Destruction Lab's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get D2B3 Neuro and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Connecticut Innovations adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/d2b3.bio/investors

# also
GET /v1/companies/d2b3.bio
GET /v1/companies/d2b3.bio/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing